Development of Oncolytic Vectors Based on Human Adenovirus Type 6 for Cancer Treatment

Human Adenovirus type 6 (HAdV-C6) is a promising candidate for the development of oncolytic vectors as it has low seroprevalence and the intrinsic ability to evade tissue macrophages. However, its further development as a therapeutic agent is hampered by the lack of convenient cloning methods. We ha...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Ivan D. Osipov, Valeriia A. Vasikhovskaia, Daria S. Zabelina, Sergei S. Kutseikin, Antonina A. Grazhdantseva, Galina V. Kochneva, Julia Davydova, Sergey V. Netesov, Margarita V. Romanenko
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2023-01-01
Edice:	Viruses
Témata:	adenovirus type 6 (HAdV-C6 Ad6) oncolytic virus virotherapy adenoviral genome modification cloning
On-line přístup:	https://www.mdpi.com/1999-4915/15/1/182
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!